MSN-50

• CAT Number: I011960
• CAS Number: 1592908-75-2
• Molecular Formula: C36H38BrN3O6
• Molecular Weight: 688.62
• Purity: ≥95%
• Synonyms: MSN-50;N-{1(S)-[[3(S)-Amino-6-(2-methoxy-ethoxymethoxy)-2,3-dihydro-benzofuran-2(R)-ylmethyl]-(4-bromo-benzyl)-carbamoyl]-2-phenyl-ethyl}-benzamide
• Target: Bcl-2 Family
• Solubility: Soluble in DMSO
• Storage: Store at 0-8 °C
• InChI: InChI=1S/C36H38BrN3O6/c1-43-18-19-44-24-45-29-16-17-30-32(21-29)46-33(34(30)38)23-40(22-26-12-14-28(37)15-13-26)36(42)31(20-25-8-4-2-5-9-25)39-35(41)27-10-6-3-7-11-27/h2-17,21,31,33-34H,18-20,22-24,38H2,1H3,(H,39,41)/t31-,33+,34-/m0/s1
• InChIKey: QRQAGDGLLUPMLV-IGOOQNSHSA-N
• SMILES: O=C(N[C@H](C(N(C[C@H]1OC2=CC(OCOCCOC)=CC=C2[C@@H]1N)CC3=CC=C(Br)C=C3)=O)CC4=CC=CC=C4)C5=CC=CC=C5

MSN-50 (Cat.No:I011960) a mesoporous silica nanoparticle with a 50 nm size, shows great promise in the treatment of neurological diseases. Its high surface area and biocompatibility make it an ideal candidate for delivering drugs directly to the brain, overcoming the blood-brain barrier. By encapsulating neuroprotective agents or targeted therapies, MSN-50 can provide controlled and sustained release, potentially improving the efficacy of treatments for conditions like Alzheimer’s, Parkinson’s, and stroke. Ongoing research aims to optimize its delivery system for neurological applications.